Histone modification-related enzymes thought to be associated with prostate cancer progression include histone methyltransferase EZH2 [29], lysine-specific demethylase 1 (LSD1) [30], histone methyltransferase SET9 [31], and others. The gene discussed is EZH2; the disease is prostate carcinoma.